Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
PLoS One ; 16(10): e0257674, 2021.
Article in English | MEDLINE | ID: mdl-34648518

ABSTRACT

INTRODUCTION: Limited population-based data exist about children with primary nephrotic syndrome (NS). METHODS: We identified a cohort of children with primary NS receiving care in Kaiser Permanente Northern California, an integrated healthcare delivery system caring for >750,000 children. We identified all children <18 years between 1996 and 2012 who had nephrotic range proteinuria (urine ACR>3500 mg/g, urine PCR>3.5 mg/mg, 24-hour urine protein>3500 mg or urine dipstick>300 mg/dL) in laboratory databases or a diagnosis of NS in electronic health records. Nephrologists reviewed health records for clinical presentation and laboratory and biopsy results to confirm primary NS. RESULTS: Among 365 cases of confirmed NS, 179 had confirmed primary NS attributed to presumed minimal change disease (MCD) (72%), focal segmental glomerulosclerosis (FSGS) (23%) or membranous nephropathy (MN) (5%). The overall incidence of primary NS was 1.47 (95% Confidence Interval:1.27-1.70) per 100,000 person-years. Biopsy data were available in 40% of cases. Median age for patients with primary NS was 6.9 (interquartile range:3.7 to 12.9) years, 43% were female and 26% were white, 13% black, 17% Asian/Pacific Islander, and 32% Hispanic. CONCLUSION: This population-based identification of children with primary NS leveraging electronic health records can provide a unique approach and platform for describing the natural history of NS and identifying determinants of outcomes in children with primary NS.


Subject(s)
Glomerulonephritis, Membranous/epidemiology , Glomerulosclerosis, Focal Segmental/epidemiology , Nephrotic Syndrome/epidemiology , Proteinuria/epidemiology , Adolescent , Biopsy , Child , Child, Preschool , Cohort Studies , Female , Glomerulonephritis, Membranous/diagnosis , Glomerulonephritis, Membranous/pathology , Glomerulosclerosis, Focal Segmental/diagnosis , Glomerulosclerosis, Focal Segmental/pathology , Humans , Male , Nephrosis, Lipoid/diagnosis , Nephrosis, Lipoid/epidemiology , Nephrosis, Lipoid/pathology , Nephrotic Syndrome/diagnosis , Nephrotic Syndrome/pathology , Proteinuria/diagnosis , Proteinuria/pathology
2.
J Am Soc Nephrol ; 32(9): 2303-2314, 2021 09.
Article in English | MEDLINE | ID: mdl-34362836

ABSTRACT

BACKGROUND: Little population-based data exist about adults with primary nephrotic syndrome. METHODS: To evaluate kidney, cardiovascular, and mortality outcomes in adults with primary nephrotic syndrome, we identified adults within an integrated health care delivery system (Kaiser Permanente Northern California) with nephrotic-range proteinuria or diagnosed nephrotic syndrome between 1996 and 2012. Nephrologists reviewed medical records for clinical presentation, laboratory findings, and biopsy results to confirm primary nephrotic syndrome and assigned etiology. We identified a 1:100 time-matched cohort of adults without diabetes, diagnosed nephrotic syndrome, or proteinuria as controls to compare rates of ESKD, cardiovascular outcomes, and death through 2014, using multivariable Cox regression. RESULTS: We confirmed 907 patients with primary nephrotic syndrome (655 definite and 252 presumed patients with FSGS [40%], membranous nephropathy [40%], and minimal change disease [20%]). Mean age was 49 years; 43% were women. Adults with primary nephrotic syndrome had higher adjusted rates of ESKD (adjusted hazard ratio [aHR], 19.63; 95% confidence interval [95% CI], 12.76 to 30.20), acute coronary syndrome (aHR, 2.58; 95% CI, 1.89 to 3.52), heart failure (aHR, 3.01; 95% CI, 2.16 to 4.19), ischemic stroke (aHR, 1.80; 95% CI, 1.06 to 3.05), venous thromboembolism (aHR, 2.56; 95% CI, 1.35 to 4.85), and death (aHR, 1.34; 95% CI, 1.09 to 1.64) versus controls. Excess ESKD risk was significantly higher for FSGS and membranous nephropathy than for presumed minimal change disease. The three etiologies of primary nephrotic syndrome did not differ significantly in terms of cardiovascular outcomes and death. CONCLUSIONS: Adults with primary nephrotic syndrome experience higher adjusted rates of ESKD, cardiovascular outcomes, and death, with significant variation by underlying etiology in the risk for developing ESKD.


Subject(s)
Cardiovascular Diseases/epidemiology , Kidney Failure, Chronic/epidemiology , Nephrotic Syndrome/complications , Nephrotic Syndrome/mortality , Adult , California , Cardiovascular Diseases/diagnosis , Delivery of Health Care, Integrated , Female , Humans , Kidney Failure, Chronic/diagnosis , Male , Middle Aged , Nephrotic Syndrome/diagnosis , Proportional Hazards Models , Retrospective Studies , Survival Rate
3.
J Nephrol ; 31(6): 907-918, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30334170

ABSTRACT

IgM secreting myelomas or lymphomas, including Waldenström macroglobulinemia, are associated with a varied spectrum of renal pathology, including intracapillary hyaline deposits, cryoglobulin, membranoproliferative glomerulonephritis, amyloid, monoclonal immunoglobulin deposition disease, cast nephropathy, and lymphoma infiltration. We report our single institution experience, and describe five cases with distinctive glomerular pathology: intracapillary IgM pseudothrombi and thrombotic microangiopathic change, with glomerular intracellular crystals in two biopsies. Two patients were hypocomplementemic at presentation. This series adds to the recent literature on paraprotein associated thrombotic microangiopathy.


Subject(s)
Capillaries/immunology , Glomerulonephritis, Membranoproliferative/immunology , Immunoglobulin M/analysis , Kidney Glomerulus/blood supply , Paraproteinemias/immunology , Thrombotic Microangiopathies/immunology , Waldenstrom Macroglobulinemia/immunology , Aged , Biomarkers/analysis , Biopsy , Capillaries/ultrastructure , Female , Fluorescent Antibody Technique , Glomerulonephritis, Membranoproliferative/blood , Glomerulonephritis, Membranoproliferative/diagnosis , Glomerulonephritis, Membranoproliferative/therapy , Humans , Immunoglobulin M/blood , Male , Microscopy, Electron , Middle Aged , Paraproteinemias/blood , Paraproteinemias/diagnosis , Paraproteinemias/therapy , Thrombotic Microangiopathies/blood , Thrombotic Microangiopathies/diagnosis , Thrombotic Microangiopathies/therapy , Waldenstrom Macroglobulinemia/blood , Waldenstrom Macroglobulinemia/diagnosis , Waldenstrom Macroglobulinemia/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...